Form 4: Evolus CEO David Moatazedi Sells Over 127,000 Shares in Open Market Transactions

Sentiment:

Insider Transaction Report 16 June 2025 4:42 PM

Evolus, Inc. CEO and Director David Moatazedi reported the sale of 127,905 shares of common stock across two transactions in mid-June 2025.

Worse than expectedThe President & Chief Executive Officer and Director, a key insider, sold a substantial number of shares, which is generally perceived as a negative signal by the market, potentially indicating a lack of confidence or that the stock is fully valued.

Summary

David Moatazedi, President & Chief Executive Officer and Director of Evolus, Inc. (EOLS), reported two sales of common stock.
On June 13, 2025, Mr. Moatazedi sold 111,323 shares of common stock at a weighted average price of $10.0531 per share, with prices ranging from $10.00 to $10.25.
On June 16, 2025, an additional 16,582 shares of common stock were sold at a weighted average price of $9.8935 per share, with prices ranging from $9.82 to $10.00.
Following these transactions, Mr. Moatazedi beneficially owns 364,927 shares of Evolus common stock.
The total value of shares sold across both transactions is approximately $1,283,141.46.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant insider selling by the CEO and a Director, which can signal a lack of confidence or a belief that the stock is overvalued.

Negatives

The President & Chief Executive Officer and Director, David Moatazedi, sold a significant number of shares (127,905 shares) in open market transactions.
Insider selling by a key executive can be interpreted by investors as a lack of confidence in the company's future prospects or that the stock price may be nearing a peak.

Risks

Potential negative investor sentiment due to significant insider selling by the CEO and a Director.
The sales could put downward pressure on the company's stock price if interpreted negatively by the market.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing reports an individual insider transaction and does not provide information on broader industry trends or competitive landscape.

Stakeholder Impact

Shareholders may interpret the insider selling as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Date	Description
06/13/2025	Date of first reported transaction where 111,323 shares of common stock were sold.
06/16/2025	Date of second reported transaction where 16,582 shares of common stock were sold, and the filing date of the Form 4.

Recommendation

hold

Keywords

Evolus, EOLS, David Moatazedi, Insider Selling, Form 4, Stock Sale, CEO, Director, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.